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Highlights 
 
 Antimicrobial use should be evidence based and prudent according to WHO guidelines. 
 In Danish weaning pigs, tetracyclines were the most frequently used antimicrobials for 
diahrroea by a substantial margin, irrespective the identified pathogen, including Brachyspira 
pilosicoli, Lawsonia intracellularis, and E.coli (F4 and F18). Tetracyclines are 2. or 3.rd choice 
antimicrobial according to the national guidelines 
 Increasing compliance with the national treatment guidelines was observed in 14% of the herds  
with laboratory finding of B.pilosicoli, suggesting that B.pilosicoli is underdiagnosed based on 
clinical criteria.  
 In herds with moderate-massive amounts of Brachyspira pilosicoli, Lawsonia intracellularis, or 
E.coli (F4 and F18), between 10% and 20% of the herds did not use antimicrobial batch 
treatment. 
 The antimicrobial use per pig appeared to decrease more in herds with negative laboratory 
results compared to herds with a moderate-massive occurrence of either of the pathogens, but 
this finding could be related to register data bias. 
  
  
Abstract  
According to international guidelines, the use of antibacterials should be evidence based and 
prudent. This register-based, cross-sectional study investigates the potential effect of laboratory 
findings on the patterns of antibacterial oral (batch) medication of weaner pigs, and the level of 
compliance with national guidelines for antibacterial use. The study population includes 1,736 
weaner herds (≈65% of all Danish weaner pigs) that were subject to laboratory analysis from the 
National Veterinary Institute on Brachyspira pilosicoli, Lawsonia intracellularis, and E.coli (F4 
and F18) in 2014. Antibacterial prescription data were obtained from the national database, VetStat. 
These showed that antibacterial prescriptions for use in weaner pigs was 8.6% lower in spring 2015 
compared to spring 2014. The antibacterial use per pig tended (p=0.08) to decrease more in herds 
with negative laboratory results compared to herds with a moderate or massive occurrence of either 
of the pathogens. Irrespective of the laboratory findings on diarrhoeal pathogens, tetracyclines were 
the most frequently used antibacterials by a substantial margin, both 3 months prior to and 2-5 
months after laboratory analysis. According to the national guidelines, tetracyclines are the second 
or third-choice antibacterial for treatment of diarrhoeal pathogens, due to resistance and co-
resistance patterns. Compliance with the guidelines increased in 14% of the herds, mostly following 
identification of B. pilosicoli within the herd. Between 10% and 20% of the herds did not use batch 
treatment, despite the presence of moderate–massive amounts of the pathogens.  
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1. Introduction 
Strategies to combat the emergence of antibacterial resistance must be targeted at supporting non-
antibacterial disease prevention and decreasing non-responsible use both in humans and animals 
(WHO, 2015). Numerous strategies have been applied to promote the prudent use of antibacterials 
(ranging from legal restrictions and treatment guidelines to information campaigns), and guidelines 
for antibacterial use in veterinary practice have been published internationally as well as in 
individual European countries (Teale and Moulin, 2012). A key step towards prudent antibacterial 
use is to decide whether the treatment is necessary, or if non-antibacterial prophylactic means 
should be implemented. In addition, the most appropriate antibacterial should be used. However, 
the decision to treat and choice of antibacterials may be affected by numerous factors other than 
professional veterinary knowledge (Busani et al., 2004, Vandeweerd et al., 2012; Gibbons et al, 
2013; De Briyne et al., 2013; Coyne et al., 2014).  
In Denmark, a number of legal interventions have been implemented in order to promote the 
prudent use of antibacterials (DANMAP 2010). The vast majority of antibacterials used in the 
veterinary field are prescribed for pigs and as a consequence, a legal intervention called “The 
Yellow Card Initiative” was enforced in 2011, which imposes restrictions and preventive measures 
in the herds with the highest consumption per pig (Anonymous, 2011; Anonymous 2014b). 
Antibacterials are usually administered to pigs (in particular weaners) per pen or section via feed or 
water, implying that healthy animals within the pens are also treated (Merle et al., 2012; Callens et 
al., 2012). However, oral administration appears to be a crucial factor in the risk of antibacterial 
resistance development (Burow et al., 2014). 
Batch treatment is often used for preventive purposes in pigs, but practice and legislation differ 
amongst the individual European countries (Callens et al., 2012). In Denmark, prophylactic use is 
illegal, and all antibacterial use is by prescription only, requiring a diagnosis based on veterinary 
examination of the animal or herd (Anonymous, 2014a). Once a herd diagnosis is established, and if 
  
potential recurrent disease is indicated, metaphylactic treatment administered by the farmer is 
allowed – legally defined as treatment “in a well-defined incubation phase” – but only if a 
Veterinary Health Advisory Contract (VAC) is in place (Anonymous, 2014a). However, the criteria 
for discontinuing repeated treatment of consecutive batches of pigs are not clear. A British focus 
group study documented that both farmers and veterinarians found it difficult to decide when to 
withdraw prophylactic treatments (Coyne et al. 2014). A recent Danish study (Pedersen et al., 2015) 
found that 84% of the farmers used some clinical inspection criteria to determine when to initiate 
treatment, while antibacterials were used systematically on a fixed day post-weaning in 16% of the 
herds, suggesting a prophylactic application. Furthermore, recurrent monthly herd-level prescription 
of the same antibacterial occurs in a large proportion of Danish weaner herds (DANMAP 2008).  
According to the WHO action plan on antibacterial resistance (Anonymous, 2015a), evidence-based 
prescribing and dispensing should be standard practice. Official Danish treatment guidelines for 
pigs relate to the selection of antibacterials for treatment of specific pathogens (DANMAP 2010), 
presupposing the identification of a causal agent. However, a recent Danish study indicated only a 
slight agreement between the veterinarians’ clinical aetiological diagnosis and the diagnosis from 
laboratory examinations for gastrointestinal (GI) bacterial pathogens (Pedersen et al. 2015). 
Furthermore, diarrhoea may have a non-infectious or viral aetiology (Pluske et al. 2002; Chase-
Topping et al. 2007). On 1
st
 June 2014, the Danish Food Authority implemented a new article in the 
Health Advisory Contracts Order (Anonymous, 2014c) targeting antibacterial group medication, 
defined as in-feed or water medication of pigs. Laboratory diagnostics became mandatory in 
relation to the oral treatment of respiratory or GI disease in herds with a Veterinary Health Advisory 
Contract (VAC), and the veterinarian must sample and submit material from untreated pigs prior to 
antibacterial group medication. Depending on the laboratory results, the veterinarian must evaluate 
(and if indicated, rectify) the treatment, and/or submit supplementary samples. Ultimately, if a 
causal bacterial pathogen is not clearly identified, alternative treatment strategies must be 
  
considered. The resulting laboratory data provide information on the presence of specific bacterial 
pathogens at herd level in a large proportion of Danish pig herds. 
The objectives of the current investigation were to: 1) determine whether the mandatory laboratory 
testing may have affected antibacterial use; 2) describe and assess the use of antibacterials for oral 
treatment of diarrhoea in weaner pigs, as well as the potential association with the laboratory 
findings; 3) evaluate whether the laboratory results were associated with a change in treatment 
strategy and compliance with the national guidelines for antibacterial treatment.   
2 Materials and Methods 
2.1 Laboratory data 
According to the legal order (Anonymous, 2014c), a submission of diagnostic samples in relation to 
the symptoms of GI disease should contain at least faecal samples, gut section or cadavers. The 
faecal samples must be collected before treatment as either a “sock sample” or a pooled faecal 
sample. It is often not possible to clearly differentiate between infections with the most common 
pathogens: Brachyspira pilosicoli (B. pilosicoli), Escherichia coli (E. coli, fimbria type F4 and 
F18), or Lawsonia intracellularis (L. intracellularis) from clinical symptoms alone (Pedersen et al., 
2015), and the legal order therefore recommends analysis for all four pathogens. If the sample is 
positive for E.coli, antibacterial sensitivity testing of E.coli isolates is recommended. Other bacterial 
pathogens such as Salmonella spp. or Brachyspira hyodysenteriae might be suspected, though these 
are unlikely; B. hyodysenteriae is extremely rare in Denmark due to the Danish SPF-system and 
Salmonella is rarely detected in relation to clinical disease in pigs (Anonymous 2016b). In a recent 
study of 20 randomly selected herds with outbreaks of diarrhoea, the four previously mentioned 
bacterial species were the only bacterial pathogens found (Pedersen et al., 2014).  
The National Veterinary Institute (NVI) analysed the vast majority of samples that were analysed 
for the four pathogens in 2014 (Anonymous 2015b). The samples submitted to the NVI for bacterial 
  
GI pathogen analysis were almost entirely faecal samples – either pooled samples or sock samples. 
The standard analysis of faecal samples includes quantitative PCR (q-PCR) for B. pilosicoli, E. coli 
(fimbriae type F4 and F18) and L. intracellularis. Analyses for individual pathogens using other 
methods were not included in the present investigation due to their sporadic occurrence. The 
outcomes from the q-PCR on pooled faecal samples were given as a categorical variable with four 
groups based on the number of copies per gram faeces: massive, moderate or low-grade occurrence 
and none identified (NI), as given in Table 1. The qPCR analyses were identical for both faecal 
samples and sock samples, but the initial preparation of the samples differed.  
The initial data set contained 3,939 submissions associated with analysis for all four pathogens, 
some of which were consecutive submissions from the same herd. Second submissions are often 
due to negative results from the prior submission, so in order to obtain information on the causal 
pathogen, consecutive submissions were considered together (see further considerations in Section 
3.2). 
2.2 Herd selection criteria 
All farms in Denmark are identified by a code (CHR-ID) within the Central Husbandry Register 
(CHR). In this study, a herd was defined as all animals within a given age group on a farm. Herds 
were included in the analysis when the following criteria were all met:  
 Laboratory analysis by q-PCR was performed for all four pathogens for samples with the 
same submission date in 2014 (→3,282 herds). 
 The age group given in the laboratory record related to weaners or was missing (→2,507 
herds). Laboratory data with no age group recorded were included in this step because 
analysis aimed at diarrhoeal pathogens was most likely to be performed on weaner pigs if 
these were present on the farm.  
 Weaner pigs were present on the farm according to the CHR (→1,813 herds). 
  
 The herd comprised at least 100 weaner pigs (according to the CHR) by 1st April 2014 and 
by 1
st
 April 2015 (→ 1,745 herds). 
 A veterinary advisory contract (VAC) was active on 1st June 2014 (→1,736 herds), as the 
legal order was only relevant for herds with an active VAC from this date. 
Farms with fewer than 100 weaners were omitted because they were likely to be sow herds, where a 
small and often variable number of pigs remain on the farm after weaning. Only farms with a VAC 
were included because legal Order 534 (2014) was aimed at these farms due to their otherwise more 
liberal access to antibacterials compared to other farms. The vast majority of the Danish pigs are 
produced on farms with a VAC. 
2.3 Antibacterial prescription data 
Around 98% of the antibacterials used in weaners were administered through feed or drinking 
water, of which 75% were prescribed for intestinal disease (Jensen et al., 2014). Data from January 
2014‒June 2015 were extracted to obtain records of antibacterial use in the 3-month period prior to 
the first herd being tested (for testing of Hypothesis 2), and to include the 3-month periods spanning 
April-June in both 2014 and 2015 (for testing of Hypothesis 1). Data on all prescriptions of oral 
antibacterial medicines prescribed for weaners were extracted from the Danish veterinary 
prescription database, VetStat (Stege et al., 2003). VetStat covers the whole country and contains 
detailed information about all veterinary prescriptions for therapeutic medicines at species level. In 
the case of production animals, each prescription is represented by a record including information 
on the date of purchase, product identity and quantity, identity of the prescribing veterinarian, CHR-
ID, targeted species, age group and disease category. VetStat data are generally considered to cover 
more than 99% of the total prescribed amounts of antibacterials for veterinary use (DANMAP 
2001).  
  
In the first step, all records relating to the sale of oral antibacterial medicines prescribed for weaner 
pigs in the 1,736 study farms between January 2014 and July 2015 were extracted. The amounts of 
the antibacterial medicines were converted into the number of defined standard doses for a pig with 
a body weight of 15 kg (Animal Daily Dose, ADD15). The standard doses defined by the Danish 
Food Administration for the Yellow Card Initiative were applied in this study (Anonymous, 2014b). 
2.4 Study design  
This study included all herds that met the selection criteria. The herds were initially grouped 
according to the laboratory findings (Table 1). Using the same cut-off values for the two tests, the 
laboratory results were transformed to a variable with three groups: negative, low-grade and 
moderate–massive (Table 1). We decided not to differentiate between E.coli F4 and E.coli F18, 
because the recommendations in the official guidelines are given at bacterial species level. The 
herds were grouped into nine diagnosis groups based on the collective laboratory analyses for the 
herd (Table 1).  
Two hypotheses were investigated: 
 Antibacterial use would be reduced in herds where none of the four bacterial pathogens could be 
identified in the laboratory (H1).  
 The choice of antibacterial agent would be adjusted towards a higher compliance with the 
official guidelines in the months following laboratory diagnosis (H2). 
With regard to the antibacterial prescription, it was assumed that the laboratory diagnosis would be 
followed by a lag phase of some months before adjustments to the treatment strategies and disease 
management would be fully implemented.  
Hypothesis 1 (H1): 
In general, the use of antibacterials in Danish weaner pigs decreased considerably during 2014-
2015, so an overall decrease in antibacterial use could be expected in the study herds. In order to 
  
address H1, we wanted to investigate whether negative laboratory results were associated with 
larger decreases in antibacterial prescription compared to cases where pathogenic levels of the 
bacteria were found. The laboratory findings were cathegorized into three groups (negative; low-
level; and moderate-massive levels of the pathogens) because the pathogenicity of E. coli (F4 and 
F18), B. pilosicoli and L. intracellularis at low levels (<10
4.5
 per gram faeces) was questionable 
(Pedersen et al., 2014). In order to investigate whether a negative diagnosis caused a decrease in 
antibacterial use over time, it was necessary to have a control group comprising herds for which the 
result of the laboratory diagnosis would not be expected to motivate a reduction in antimicrobial 
use. Herds with moderate–massive occurrence of any of the pathogens were used as a control group 
because this is mostly associated with diarrhoea, and the finding of a pathogenic level of the 
bacteria would not prompt the discontinuation of medication. Herds with low levels of the 
pathogens were omitted because the significance was questionable, and consequently the effect on 
antimicrobial use was unpredictable. 
All oral antibacterial use was included in this part of the study, because antibacterials for oral use in 
weaners are almost exclusively (~75-80%) used for the treatment of diarrhoea; even oral 
antibacterials prescribed for other indications might be used for GI disease treatment by the farmer. 
H1 was investigated by comparing the antibacterial use over the period March-May 2014 (before 
the legislation was implemented) to that of March-May 2015. The latter period was chosen to limit 
the effect of seasonal variation in antibacterial prescription. In addition, changes in disease 
management were expected to affect antibacterial use until spring 2015 on farms that received the 
final laboratory diagnosis in the last quarter of 2014. 
The treatment incidence (TI) was estimated for both periods based on the number of weaner pigs (n) 
registered in the CHR by 1
st
 April in the same year, as: 
𝑇𝐼 =
#ADD15 
weaning pig produced
=
4∗nADD15
𝑛∗𝑟 
                         (1) 
  
where nADD15 is the number of standard doses prescribed within the respective 3-month period and 
r=6.64 is the number of rotations per year in the weaner section. The number of rotations was 
estimated from 2014 productivity data from the Pig Research Centre (Jessen, 2015).  
The TI was also calculated at national level (using data on the number of breeding sows from 
Statistics Denmark) in order to validate the TI as calculated for the study herds, and to evaluate 
whether herds with moderate–massive pathogen load constituted a representative control group. The 
number of weaners produced during March-May 2014 and March-May 2015 was estimated as:  
weaners produced=Nsows *(wsow* 91 days/365 days)* (1-mortalityw) = 7.4* Nsow          (2) 
where Nsows is the number of breeding sows on 1
st
 April in the given year (Statistics Denmark, 
2016); wsow = 30.6 weaned piglets/ sow-year in 2014; mortalityw=2.9% for weaner pigs from 
weaning to 30 kg body weight in 2014 (Jessen, 2015). The national TI was subsequently estimated 
for each 3-month period, including all oral antibacterial prescriptions for weaners. 
Hypothesis 2 (H2) 
The objective was to investigate whether the choice of antibacterials (i.e., whether the prescription 
pattern for treatment of GI disease) changed depending on the laboratory diagnosis. Only 
antibacterials prescribed for oral treatment of GI disease were included in this part of the study, 
since the main focus was on the choice of antibacterial for treating GI disease. A small number of 
prescription records that lacked an indicated target disease were also included as it was deemed that 
GI disease was the most likely reason for treatment. 
In theory, antibacterial prescription patterns at herd level show an infinite variation. However, in 
most herds, only one antibacterial agent is regularly prescribed for oral use over extended periods of 
time (DANMAP 2008). In most cases, a single antibacterial agent makes up the vast majority of 
total antibacterials prescribed for a given farm, and we refer to this antibacterial class as the 
principal antibacterial for that farm. In some farms, more antibacterials are used, but one 
  
antibacterial agent prevails. The antibacterial agents within an antibacterial class (Anatomical 
Therapeutic Classification, ATCvet level 4 or 5; www.WHOcc.no) were summed over the 3-month 
period for each herd, and the principal antibacterial was identified.  
Antibacterial classes were grouped at the fourth or fifth ATC level, according to the official 
treatment guidelines (see Table 2). For example, all aminoglycosides for oral use were grouped into 
one class, whereas colistin was kept in a separate class. Across the study herds, the principal 
antibacterials comprised 80% and 77% of the total oral antibacterials prescribed within the 3-month 
periods before and after the laboratory analysis, respectively.  
For each of the four bacterial pathogens, all antibacterial classes were defined as first-choice and 
second-choice antibacterials according to the official treatment guidelines (Table 2). Third-choice 
antibacterials were defined as those not recommended in the guidelines (as a first or second-choice 
antibacterial) for the specific pathogen. In the case of co-infection with L. intracellularis and 
B. pilosicoli, the first and second-choice antibacterials were the same as for single infections. In the 
case of co-infection with E.coli, the veterinarian may choose to: 1) treat the pathogen considered to 
be responsible for the observed symptoms; 2) use two first-choice antibacterials in parallel, thus 
treating both/all pathogens; 3) use a second-choice antibacterial that may treat both/all infections. It 
was decided that all antibacterials defined as first-choice antibacterials for one pathogen should also 
be considered as first-choice antibacterials in the case of co-infections (Ad 1 and 2). Therefore, if 
both colistin and tiamulin were used to treat a co-infection with E.coli and L. intracellularis, one of 
them would be defined as the principal antibacterial, and the choice of drug for the herd would be 
classified as a first-choice antibacterial. In the case of a co-infection with E.coli, tetracyclines were 
defined as second-choice antibacterials, in addition to those recommended as second-choice 
antibacterials for both pathogens (Ad 3).  
2.5 Descriptive and Statistical Analysis 
  
Data cleansing, tabulations and data analysis were performed in SAS® EG 6.1. The data were first 
analysed descriptively: 
Hypothesis 1 
The change in TI (ΔTI) from spring 2014 to spring 2015 was calculated for each herd, and the 
distribution was displayed as a box plot for each diagnosis group (negative, low-grade and 
moderate–massive). The descriptive analysis showed that the distribution of ΔTI within the smaller 
groups of herds (negative and low-grade) was not significantly different from the normal 
distribution (Shapiro-Wilks test of normality). However, the ΔTI in the large group of herds 
(moderate–massive) deviated significantly from the normal distribution, and logarithmic, square 
root, and other transformations did not result in a near normal distribution. Therefore, a one-sided 
Wilcoxon rank sum test was applied in order to test whether the ΔTI in groups of herds with 
negative lab results were lower than the ΔTI in herds with moderate–massive occurrence of the 
pathogens.  
Hypothesis 2  
The choice of principal antibacterials within the 3-month period prior to sample submission was 
compared to that within the 3-month period following the 2-month lag phase after the last 
laboratory results in 2014. The choice of principal antibacterial was plotted in a histogram for each 
combination of pathogens. Statistical analysis of changes in the principal antibacterial was not 
found to be relevant (cf. Section 3.2). For each herd, the principal antibacterial was defined as the 
first, second or third choice for each period. The change in antibacterial was subsequently defined 
as being either compliant or non-compliant with the guidelines. A chi-square analysis was applied 
in order to test for an association between the level of compliance with the guidelines before 
laboratory analysis and the change in the level of compliance. 
3. Results 
  
3.1 Treatment incidence (Hypothesis 1) 
In this section, the term antibacterial use refers to the prescription of oral antibacterials for 
treatment in weaner pigs within the 3-month periods of March to May 2014 and March to May 
2015, and pigs refers to weaner pigs (up to 30 kg body weight). 
At a national level, the treatment incidence was an estimated 6.88 ADD15/ pig produced in March-
May 2014 and 6.24 ADD15/pig produced in March-May 2015 (Figure 1), corresponding to a 9.3% 
decrease in TI. In the same period, the crude antibacterial use (in ADD not adjusted for population 
size) decreased by 8.6%, while the production of weaner pigs increased by almost 1%.  
Estimating the herd-level TI in the study herds gave some outliers up to TI=63 ADD15 per weaning 
pig produced (i.e. 63 daily doses per pig within the 52-day production period). This level is most 
certainly biased, as it corresponds to more than one daily dosage per day for all pigs in the weaning 
herd. Nineteen outlier herds with between 22 ADD15 and 69 ADD15 per weaning pig in at least one 
of the 3-month periods (mostly in 2014) were excluded from this part of the study, as the CHR 
records for these herds also supported the notion that the results for these herds may be biased. For 
17 of the 19 herds, the number of pigs recorded increased significantly (by 41%-633%) between 
2014 and 2015. As a result, levels in 2015 were within the 5-95% percentiles of TI [0–11 ADD15 
/weaning pig] for the remaining herds. This supports the idea that the outliers were caused by biased 
CHR records in the first period (2014). The number of pigs registered in one outlier herd decreased 
by 75% from 2014 to 2015; in the last outlier herd, the number of pigs registered was very low in 
both periods. 
For the remaining 1,717 herds, the mean TI and percentiles for each group of herds are shown in 
Figure 1. The estimated decrease in antibacterial use appeared to be larger in the group of herds 
without the laboratory-confirmed presence of E. coli (F4 or F18), B. pilosicoli or L. intracellularis 
(negative). However, the variance was large in all three groups. A one-sided Wilcoxon Rank Sum 
  
Test showed that the difference between the ΔTI of the negative group was not significantly larger 
(p=0.08) than the ΔTI of the group with moderate–massive occurrence of the pathogens. 
The total antibacterial use in the 1,717 study herds corresponded to 72.5% of the national 
antibacterial use in both periods, and the decrease in crude (unadjusted) antibacterial use 
corresponded to changes at national level. In the study herds, antibacterial use measured in ADD15 
decreased by 8.5% from spring 2014 to spring 2015. This was similar to the decrease observed at 
national level, but the estimated TI of all three groups of study herds was lower than the estimated 
TI at national level (Figure 1). The main reason for this difference was that the number of pigs 
recorded in the CHR register in the second quarter overestimated the number of weaner pigs in 
Denmark by 15% in 2014 and 26% in 2015 compared to the number of weaner pigs calculated from 
national census data and productivity data. The included herds comprised approximately 65% of the 
weaners registered in active herds in the CHR in both 2014 and 2015. 
3.2 Choice of antibacterials (Hypothesis 2) 
Multiple submission dates from the same herd were observed for 253 herds. Of these, 83 herds were 
omitted because more than 3 months had passed between the first submission and last result. This 
was based on the assumption that a longer period between the first submission and last laboratory 
result would result in a greater probability of other factors affecting the choice of antibacterial. The 
final data set comprised 1,653 weaner herds, including 83 herds with negative laboratory results, 
102 herds with low-grade occurrence, and 1,468 with moderate–massive occurrence of the 
pathogens. Across herds, the principal antibacterial in each herd comprised a total of 80% and 77% 
of the total oral antibacterial prescription for GI treatment in weaners over the two observation 
periods. In each observation period, the principal antibacterial made up 100% of oral antibacterial 
use in more than half of the herds.  
Figure 2 shows a comparison of the principal antibacterials before and after diagnosis for each 
laboratory diagnosis category. For all categories, tetracyclines were the most frequently used 
  
principal antibacterial both before and after laboratory analysis, despite not being recommended as 
a first choice for any of the four infections. 
Table 3 shows changes in the choice of antibacterial category before and after laboratory diagnosis 
of moderate–massive occurrence of specific bacteria. In the vast majority of herds, the category of 
antibacterial was maintained (corresponding to the diagonal categories in Table 3). This number 
was significantly higher than expected from random distributions (χ2=1214, p<0.001), which shows 
that the probability of maintaining the same category is statistically higher than the probability of 
changing.  
Among the herds that received a third-choice antibacterial before laboratory analyses, 75% 
(376/502) continued to use a third-choice antibacterial after the pathogen(s) were identified. In 
almost all of these herds (371/376), the presence of E. coli was confirmed (sometimes together with 
other pathogens), and this group mainly used tetracyclines or macrolides (304/371).  
In the 383 herds that continued with second-choice antibacterials, the vast majority used 
tetracyclines (65% of herds before and 48% of herds after laboratory analyses).  
When the submissions tested positive for particular pathogens, compliance with the guidelines was 
defined as either a change in antibacterial agent towards a first-choice antibacterial, or the continued 
use of a first-choice antibacterial. In addition, the use of a second-choice antibacterial could be 
considered compliant if a third- or second-choice antibacterial was previously used. Finally, 
discontinuing the treatment and managing herd issues using other methods would also comply with 
the general principles of the guidelines. In contrast, a change from using either no antibacterials or 
first-choice antibacterials to using second or third-choice antibacterials, or changing from second to 
third-choice antibacterials, or maintaining a third-choice antibacterial would all be considered non-
compliant. 
  
According to this definition, 582 herds of the 1,468 herds with moderate–massive amounts of the 
pathogens did not comply with the guidelines after the laboratory analyses (yellow area in Table 3). 
Nevertheless, there was a marginal increase in the number of herds receiving first-choice 
antibacterials or discontinuing treatment (increasing from 423 to 462 herds). The proportion of 
herds going against the guidelines among those that previously complied (according to subsequent 
findings) was 21%. The relative risk of acting in accordance with the guidelines (Table 3) for those 
who previously complied with the recommendations was 3.1 (p<0.001; 95% CI: [2.7-3.7]). 
Conversely, the proportion of herds that did not comply with the guidelines among those previously 
receiving a third-choice antibacterial was 0.76. The relative risk of non-compliance after the 
laboratory results for those previously using third-choice antibacterials was RR=3.5 (p<0.001; 
95%CI: [3.1-4.0]).  
The prescription patterns of the 102 herds with a low-grade occurrence of the pathogens were 
generally similar to those in herds with a moderate–massive occurrence: second and third-choice 
antibacterials made up two thirds of principal antibacterials both before (69/102) and after (71/102) 
laboratory analyses. Prior to the laboratory analysis, 16 herds received no antibacterials for oral use, 
but five of these herds initiated oral antimicrobial use after laboratory analysis. In contrast, one herd 
discontinued antibacterial treatment after laboratory analysis showed low-grade occurrence. 
The majority of the 83 herds in which none of the four pathogens were identified used 
antibacterials, mainly tetracyclines (32/83 herds after laboratory analyses; Figure 2). Prior to 
submission, oral antibacterials were not prescribed in 20 of the 83 herds, which increased to 23 
herds following the laboratory results. Only 14% (9 herds) of the 63 herds that used antibacterials 
prior to submission discontinued the medication. Conversely, 30% (6 herds) of the 20 herds that did 
not use antibacterials prior to submission received oral medication after the laboratory analyses.  
 
  
4. Discussion  
Antibacterial prescription patterns are highly variable over time and influenced by numerous 
clinical, economic and social factors that vary between and within farms, as well as between 
veterinarians. This study aimed to investigate the potential effect of new legislation imposing 
mandatory laboratory analysis prior to the antibacterial batch treatment of pigs. Although it is not 
possible to determine causal relationships in this type of study, it is possible to investigate whether 
changes (coincidental or causal) in prescriptions may have occurred in temporal and causal relation 
to the legislation. The main objectives of the new legislative Order 334/2014 were to support 
evidence-based prescriptions (i.e. to ensure that a bacterial infection is actually present in cases of 
batch medication), to ensure that the antibacterial of choice is directed at the actual pathogen, and to 
support the consideration of differential diagnosis and the alternative management of disease. 
Oral antibacterial medication of weaner pigs (measured in ADD) decreased by 8.6% from spring 
2014 to spring 2015. Across the study herds, prescriptions decreased by 8.5% in March-May 2015 
compared to the same period in 2014 (i.e., very close to the decrease observed at national level). 
Furthermore, antibacterial use in the study herds amounted to approximately 73% of the national 
use in both periods, supporting that the study herds may be considered representative of the 
population. Nevertheless, it is possible that a minority of the herds (i.e. those submitting to other 
laboratories) may exhibit different patterns. As bacterial pathogens were detected in the vast 
majority of the study herds, it is unlikely that the general decrease in oral antibacterials observed 
nationally was caused by the mandatory laboratory analyses. It is more likely that the lowered 
threshold of the Yellow Card Initiative imposed from 28
th
 February 2014 contributed to the 
decrease (Anonymous, 2014b). 
Previous findings (Pedersen et al., 2015) have indicated that the clinical importance of low-grade 
infection was questionable; non-bacterial causalities were considered likely in diarrhoeal outbreaks 
  
(designated low-pathogen outbreaks) where only a small number of pigs in the batch experienced a 
bacterial intestinal disease (Pedersen et al. 2014).  
A low specificity of 0.60 and a high sensitivity=0.96 have been found for bacterial pathogenic load 
(qPCR) as a criteria for identifying diarrhoea with bacterial aetiology (Pedersen et al., 2014). In 
accordance with this, we found that the pathogens can be present in moderate–massive amounts 
without associated antibacterial batch treatment: in herds with moderate–massive occurrence of the 
pathogens, the proportion that did not receive batch treatment varied between 10-20% depending on 
the diagnosis group. In particular, the proportion increased in groups of herds where only 
L. intracellularis (up to 22%) or B. pilosicoli (up to 24%) were identified in the laboratory. Our 
findings suggest that the bacteria may not cause diarrhoea in a large proportion of herds, despite the 
moderate–massive load of the pathogens.  
Moderate–massive loads of at least one of the pathogens E.coli, (F4 and F18), B. pilosicoli and L. 
intracellularis were found in 89% of the study herds by PCR analyses, while none of the four 
pathogens were detected in 5% of the herds. When pathogenic bacteria were detected, there was no 
increased incentive to discontinue antibacterial treatment. Accordingly, the decrease in antibacterial 
use per pig from spring 2014 to spring 2015 tended to be more prominent (non-significant, p=0.08) 
in the group of herds where no pathogen was identified. These findings support the view that 
disease occurrence was lower in the group with negative laboratory diagnosis, or that it was 
possible to manage disease by means other than antibacterial treatment in some of the herds. This is 
in accordance with the intention of the legislation. However, the finding is not statistically 
significant and must be interpreted with caution due to the bias of the denominator (the number of 
pigs at herd level). The most valid data on the number of live pigs at national level are from 
Statistics Denmark, and are based on decennial total counts and extrapolation based on index herds. 
These have a high level of agreement (>99%) with estimates of live pig numbers based on 
  
productivity, production and export data (Jensen et al., 2014). Comparison to these data indicated an 
increasing overestimation of the number of pigs registered in the CHR. As a consequence, the TI 
calculated at herd level in the present study was most likely underestimated, and the estimated 
average decrease in TI was likely to be overestimated. Accordingly, antibacterial use decreased 
between 2014 and 2015 by 1.1 ADD15 /pig produced in the study herds, compared to 0.64 ADD15 
/pig produced at national level (Figure 1). Nevertheless, we have no reason to believe that the 
increasing overestimation of the number of pigs varied depending on the laboratory diagnoses (i.e. 
between the three groups of pig herds). We therefore consider the trend towards a larger decrease in 
antibacterial use in herds with a negative diagnosis may be real.  
When only a small proportion of the pigs are diarrhoeic and the bacterial load is low, it is unlikely 
that the bacteria are causing the diarrhoeal outbreaks in the herds, and such outbreaks should 
probably be solved by other interventions (Pedersen et al., 2014). Low bacterial load (<35,000 or 
10
4.5 
per gram faeces) identified by qPCR was found to have a high specificity for identifying low-
pathogen diarrhoea (Pedersen et al., 2014). In our study, the criteria for identifying low pathogen 
load were only slightly different, as the pathogen load was measured for the individual pathogens. 
No bacterial pathogens were identified in 83 herds (5%), and a low pathogen load was found in 102 
(6%) of 1,653 herds. It is possible that some of these findings were due to an inappropriate 
sampling procedure, or some herds could have a positive diagnosis of GI bacterial pathogens from 
another laboratory. However, the proportion of herds with diarrhoeal outbreaks, without bacterial 
pathogens was even higher in a previous study (11%), although not significantly different from our 
findings (Pedersen et al., 2015). This may indicate that some of the herds in our study had diarrhoea 
even though none of the bacterial pathogens were found, and could explain why the majority 
(150/187) of the herds with negative or low-pathogenic findings continued (or initiated) 
antibacterial treatment 2-5 months after the laboratory analysis, despite this not being the most 
appropriate intervention, at least at the time of sample submission. In herds with low-pathogenic 
  
diarrhoea, Pedersen et al. (2015) found changes in aetiology in the majority of herds within 4-8 
weeks, and only 16% of herds (95%CI: 0.05-0.36) displayed the same infection over three 
consecutive diarrhoeal outbreaks. This may also explain the continued use of antibacterials in herds 
with low levels of pathogenic bacteria in our study. 
The most common laboratory finding was E. coli (F4 and F18), identified in 55% of the herds. This 
is in accordance with a previous study (Pedersen et al., 2015), where E.coli (F4 and F18) was 
identified in 61% (22/36) of the herds. In addition, E.coli was identified in 62% of the herds with 
moderate–massive occurrence of the pathogens, most frequently as the only pathogen (26% of the 
herds), or as a co-infection with L. intracellularis (19% of the herds). In herds with these two 
diagnoses, tetracyclines were by far the most common principal antibacterial before and after 
laboratory diagnosis (37% increasing to 39% of the herds). This was surprising, as tetracyclines are 
third-choice antibacterials for the treatment of E.coli infections due to the frequent occurrence of 
tetracycline resistance in pathogenic E. coli according to the official guidelines (64% of E.coli O149 
were tetracycline resistant in 2006-2008; Anonymous, 2016a). Preliminary results from the 
Laboratory for Pig Disease (part of the Danish Pig Research Centre, SEGES P/S) suggested that the 
level of resistance in E. coli O149, O138, O139, and O141 was at the same level in the periods 
2014–2015 and 2006–2008 (Data from Laboratory for Pig Disease (SEGES P/S); Svensmark B., 
personal communication, 2015). It is likely that antibacterial resistance testing was performed in 
some of the herds, yet the frequent use of tetracyclines suggests that they were used in some herds 
with tetracycline-resistant pathogenic E.coli.  
Only minor changes in the choice of principal antibacterials were observed across herds. These 
occurred in 28% of the herds, of which only 14% exhibited a shift towards higher compliance with 
the guidelines. This was much lower than expected from a previous study (Pedersen et al. 2015), in 
which antibacterial treatment was changed in 63% of the herds, and for 32% (18-50%) of the herds, 
  
the veterinarian indicated the change was a response to the laboratory findings. The 
differencebetween in the two studies in respect to responses to laboratory resuls could be due to 
different motivation for participation/submission of samples: The subsample of veterinarians 
responsible for the 36 herds in the Pedersen et al. (2015) study were likely to be more motivated for 
using the laboratory results because the herds represents a minority and the participation was 
voluntary.  
In our study, the herds that complied with the guidelines prior to laboratory analysis were more 
likely (RR=3.1 (p<0.001; 95% CI: [2.7-3.7]) to comply with the guidelines after laboratory 
analysis. However, a surprisingly high proportion (21%) of the herds that complied with the 
guidelines prior to laboratory analysis subsequently made a shift in antimicrobial choice that went 
against the guidelines. 
The recommended first-choice antibacterials were rarely the principal antibacterial before or after 
laboratory analysis. Only in the case of a single infection with B. pilosicoli did the proportion of 
herds using pleuromutilins as first-choice antibacterials increase considerably (from 4% to 15% of 
the herds). The reason could be a general underestimation by veterinarians of the herd-level 
occurrence of B. pilosicoli in particular, as suggested in the previous study (Pedersen et al., 2015). 
A decrease in the use of tetracyclines as principal antibacterials was almost exclusively observed in 
the diagnosis groups involving B. pilosicoli (including co-infections), yet tetracyclines remained the 
most frequently used antibacterials, even for B. pilosicoli. In general, tetracyclines remained the 
most frequently chosen principal antibacterial, irrespective of laboratory diagnosis, despite not 
being a recommended agent for the treatment of infection with any of the four pathogens. In the 
official guidelines, tetracyclines are second-choice antibacterials for the treatment of diarrhoea 
caused by L. intracellularis and B. pilosicoli. 
  
A driving factor in the high proportion of herds using tetracyclines may be the broad spectrum of 
tetracyclines, as they are reasonably effective against all four pathogens (with the exception of 
E.coli carrying tetracycline-resistance genes). Furthermore, cost is a motivating factor affecting 
antibacterial prescription in the pig sector, and a previous study showed that the cost of a cure 
dosage of tetracyclines was lower than for other antibacterials (except tiamulin) in Denmark 
between 2005 and 2010 (Anonymous, 2009; Anonymous, 2010; Sheehan 2013). The cost-
effectiveness of antibacterial treatment compared to preventive interventions may also be important. 
In addition, pressure and the level of compliance from the farmer may influence the veterinarian’s 
choice of antibacterial (Coyne et al., 2014). Pedersen et al. (2015) found an agreement of only 0.18 
(95%CI: 0.08-0.34) between veterinarians’ diagnosis at sampling and the laboratory diagnosis. In 
particular, the occurrence of L. intracellularis in the herds was highly overestimated by the 
veterinarian compared to the laboratory diagnoses. Such uncertainty regarding diagnoses could 
partially explain the frequent use of broad-spectrum tetracyclines prior to laboratory analysis in the 
present study, yet it cannot explain the continued use of third-choice antibacterials after the 
diagnosis.   
 
5. Conclusion  
The use of oral antibacterials in weaner pigs decreased by 8.6% on a national level in spring 2015 
compared to spring 2014. It is likely that this is due to factors other than the mandatory laboratory 
testing (e.g. the lowered threshold of the Yellow Card Initiative imposed from 28
th
 February 2014). 
The use of antibacterials tended to decrease more in herds with no confirmed presence of the 
pathogens, although this was not significant and possibly due to bias. Whether there is a causal 
relationship with the mandatory laboratory testing cannot be determined from this study.  
Tetracyclines were the most common antibacterials used for GI disease in weaners, both prior to 
submission of samples and 2-5 months after laboratory analyses, irrespective of which intestinal 
  
pathogen was identified. The choice of principal antibacterial changed towards higher compliance 
with the guidelines after laboratory analysis in only in a minority of the herds (14%). Increased 
compliance was mostly observed after identification of B. pilosicoli. Non-compliance with the 
guidelines after laboratory analysis was mostly related to the use of tetracyclines in herds with 
E.coli infections. Furthermore, the risk of non-compliance was significantly higher (RR=3.5) when 
a third-choice antibacterial was used prior to laboratory analysis, when compared to all other cases. 
The pattern of prescription was almost unchanged across the group of herds with moderate–massive 
occurrence of E. coli and/or L. intracellularis. Tetracyclines remained the most frequently used 
antibacterials by a substantial margin for all diagnoses, despite not being first-choice antibacterials 
according to the official guidelines. However, tetracyclines are effective against L. intracellularis. 
Sensitivity to tetracycline is detected in only one third of E. coli isolated from diarrhoea, indicating 
the need for current E. coli sensitivity testing prior to use of tetracyclines.  
Between 10-20% (depending on the diagnosis group) of the herds did not use batch treatment, 
despite the presence of pathogens in moderate–massive amounts. Further studies are needed to 
identify other factors affecting the level of disease and the need for antibacterial batch treatment in 
herds with moderate–massive occurrence of the pathogens. 
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Table 1. Classification of weaning pig herds based on laboratory testing for gastrointestinal 
pathogens
a 
Diagnosis group Definition 
Number of herds
b
 
H1 H2 
Negative   All samples tested negative for the 4 pathogens 85 83 
Low-grade occurrence 
Positive (>10
3
 copies/gram) for at least one 
pathogen, less than moderate occurrence of all 
pathogens 
102 102 
Moderate–massive occurrence    
ECOLI positive >10
5
 copies/gram faeces 
1,530 
442 
BPILO positive  >10
4
 copies/gram faeces 46 
LAWS positive  >10
5
 copies/gram faeces 171 
ECOLI and LAWS positive 
 
LAWS >10
5
 and/or ECOLI> 10
5
 copies/gram 
faeces 
Both pathogens >10
3 
copies/gram faeces 
332 
ECOLI and BPILO positive 
 
BPILO >10
4
 and/or ECOLI>10
5
 copies/gram 
faeces 
Both pathogens >10
3 
copies/gram faeces 
94 
LAWS and BPILO positive 
BPILO >10
4
 and/or LAWS>10
5
 copies/gram 
faeces 
Both pathogens >10
3 
copies/gram faeces 
187 
LAWS, BPILO and ECOLI 
positive 
  
BPILO >10
4 
and/or LAWS >10
5
 and/or ECOLI> 
10
5 
copies/gram faeces 
Three pathogens >10
3 
copies/gram faeces 
196 
Total  1,717 1,653 
a
: Laboratory analysis for GI pathogens: ECOLI= E. coli; BPILO= B. pilosicoli; LAWS= L. intracellularis. 
b
: Number of herds included for investigation of Hypothesis 1 (H1) and Hypothesis 2 (H2) respectively, after omission 
of outliers (for H1) and omission of herds with more than 3 months between submission and final laboratory result 
(H2). 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table 2. Definition of first- and second-choice antibacterials
a
 for treatment of diarrhoeal bacterial 
pathogens 
Bacterial pathogen 
First-choice 
antibacterial Second-choice antibacterial 
L. intracellularis tiamulin, valnemulin 
tetracyclines, 
lincosamide/spectinomycin, 
macrolides, sulfonamide/trimethoprim 
B. pilosicoli tiamulin, valnemulin 
tetracyclines, lincosamide, macrolides, 
sulfonamide/trimethoprim 
E. coli colistin 
aminoglycosides, 
sulfonamide/trimethoprim, 
aminopenicillins 
L. intracellularis  
B. pilosicoli 
tiamulin, valnemulin 
tetracyclines, 
lincosamide/spectinomycin, 
macrolides, sulfonamide/trimethoprim 
L. intracellularis  
E. coli
1
 
tiamulin, valnemulin, 
colistin 
tetracyclines, 
sulfonamide/trimethoprim, 
lincosamide/spectinomycin 
B. pilosicoli  
E. coli
1
 
tiamulin, valnemulin, 
colistin 
tetracyclines, 
sulfonamide/trimethoprim, 
lincosamide/spectinomycin 
E. coli  
L. intracellularis 
B. pilosicoli
1
 
tiamulin, valnemulin, 
colistin 
tetracyclines, 
sulfonamide/trimethoprim, 
lincosamide/spectinomycin 
a 
For single infections, the definition of first and second choice follows the National Guidelines (Anonymous, 2015a). 
For co-infections, the definitions are defined for this study by deduction from the guidelines for single infections, as 
explained in the text. 
  
  
 
Table 3 Classification
a
 of principal antibacterial choice at herd level before and after laboratory 
identification of moderate–massive amountsa of the pathogens 
 
 
 
Choice of antibacterial 
following
b
 laboratory analysis Total 
None 1st 2nd 3rd 
 
Number of herds (%)  
C
h
o
ic
e 
o
f 
an
ti
b
ac
te
ri
al
 
p
ri
o
rc
 t
o
 l
ab
o
ra
to
ry
 
an
al
y
si
s 
None 109 (7) 10 (1) 60 (4) 46 (3) 225 (15) 
1st 19 (1) 122 (8) 39 (3) 18 (1) 198 (13) 
2nd 47 (3) 70 (5) 383 (26) 43 (3) 543 (37) 
3rd 45 (3) 40 (3) 41 (3) 376 (26) 502 (34) 
Total 220 (15) 242 (16) 523 (36) 483(33) 1,468 
a 
According to official guidelines:
 
the principal antibacterial defined as first, second or third choice according to Table 2; 
third choice comprises antibacterials that are not recommended for the treatment of E.coli, B. pilosicoli or 
L. intracellularis. The shaded area represents changes in antibacterial choice that are non-compliant with the official 
guidelines. 
b
 Category of principal antibacterial 61-152 days after the results of laboratory analysis. 
c
 Category of principal antibacterial 91 days before submission for laboratory analysis. 
  
  
Figure legends 
 
 
Figure 1: Herd-level antibacterial use
1
 per weaning pig produced in spring 2014 and spring 2015 
within groups of herds with different laboratory findings
2
.  
1) Distribution of antibacterial use per pig at herd level within each group of herds: box plot of the mean; bars: 25
th
 and 
75
th
 percentiles; lines: 5
th
 and 95
th
 percentiles. Note: the estimated use per pig produced is likely to be underestimated 
because the number of weaner pigs registered in the CHR overestimates the number of pigs in general. Green lines 
show the national level for comparison. 
2) Laboratory finding of E. coli (F4 and F18), B. pilosicoli or L. intracellularis by PCR.  
 
 
Figure 2: Choice of antibacterial for oral use
1
 depending on laboratory findings of moderate–
massive amounts of the diarrhoeal pathogens
2
. 
1: Principal antibacterials for herd treatment. 2: B. pilosicoli, E.coli (F4 or F18) or L. intracellularis. 
       3 months before laboratory analysis.          2–5 months after laboratory analysis. 
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a: Principal antimicrobials for herd treatment. b: B. pilosicoli, E.coli (F4 or F18) or L. intracellularis.
       3 months before laboratory analysis.          2–5 months after laboratory analysis.
Figure 2 Choice of antimicrobial for oral usea depending on laborative findings of moderate–massive 
amounts of the diarrhoal pathogensb 
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Negative laboratory results 
83 herds 
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E. coli 
 442 herds 
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 B. pilosicoli  
46 herds 
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L. intracellularis 
171 herds 
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E. coli and L. intracellularis 
332 herds 
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E. coli and B. pilosicoli 
94 herds 
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L. intracellularis and B. pilosicoli 
187 herds 
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E.coli, L. intracellularis and B. pilosicoli 
196 herds 
